Cargando…

Re: Trivizki et al. Local Geographic Atrophy Growth Rates Not Influenced by Close Proximity to Non-Exudative Type 1 Macular Neovascularization

Detalles Bibliográficos
Autores principales:	Pfau, Maximilian, Schmitz-Valckenberg, Steffen, Holz, Frank G., Fleckenstein, Monika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106973/ https://www.ncbi.nlm.nih.gov/pubmed/35536717 http://dx.doi.org/10.1167/iovs.63.5.10

Ejemplares similares

Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression
por: Thiele, Sarah, et al.
Publicado: (2021)

Determinants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Künzel, Sandrine H., et al.
Publicado: (2020)

Local Geographic Atrophy Growth Rates Not Influenced by Close Proximity to Non-Exudative Type 1 Macular Neovascularization
por: Trivizki, Omer, et al.
Publicado: (2022)

Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy
por: Pfau, Maximilian, et al.
Publicado: (2022)

Author Response: Local Geographic Atrophy Growth Rates Not Influenced by Close Proximity to Non-Exudative Type 1 Macular Neovascularization
por: Trivizki, Omer, et al.
Publicado: (2022)

Mesopic and Dark-Adapted Two-Color Fundus-Controlled Perimetry in Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
por: von der Emde, Leon, et al.
Publicado: (2018)

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
por: von der Emde, Leon, et al.
Publicado: (2019)

Impact of lesion location and functional parameters on vision-related quality of life in geographic atrophy secondary to AMD
por: Künzel, Sandrine H., et al.
Publicado: (2023)

Evaluation of Two Systems for Fundus-Controlled Scotopic and Mesopic Perimetry in Eye with Age-Related Macular Degeneration
por: Steinberg, Julia S., et al.
Publicado: (2017)

Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
por: Pfau, Maximilian, et al.
Publicado: (2021)

Clinical and Genetic Factors Associated with Progression of Geographic Atrophy Lesions in Age-Related Macular Degeneration
por: Grassmann, Felix, et al.
Publicado: (2015)

Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration
por: Sassmannshausen, Marlene, et al.
Publicado: (2020)

Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation
por: Behning, Charlotte, et al.
Publicado: (2021)

AI-based structure-function correlation in age-related macular degeneration
por: von der Emde, Leon, et al.
Publicado: (2021)

Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO)
por: Deckert, A, et al.
Publicado: (2005)

Geographic Atrophy Segmentation Using Multimodal Deep Learning
por: Spaide, Theodore, et al.
Publicado: (2023)

Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report
por: Saßmannshausen, Marlene, et al.
Publicado: (2022)

Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence
por: Pfau, Maximilian, et al.
Publicado: (2021)

From Genes, Proteins, and Clinical Manifestation: Why Do We Need to Better Understand Age-Related Macular Degeneration?
por: Schmitz-Valckenberg, Steffen, et al.
Publicado: (2022)

Intersession Repeatability of Structural Biomarkers in Early and Intermediate Age-Related Macular Degeneration: A MACUSTAR Study Report
por: Saßmannshausen, Marlene, et al.
Publicado: (2022)

ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD)
por: Liakopoulos, Sandra, et al.
Publicado: (2020)

Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report
por: Garzone, Davide, et al.
Publicado: (2022)

Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration
por: Dhrami-Gavazi, Elona, et al.
Publicado: (2015)

CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD
por: Scholl, Hendrik P. N., et al.
Publicado: (2009)

Author Correction: Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report
por: Garzone, Davide, et al.
Publicado: (2023)

Comparison of Green Versus Blue Fundus Autofluorescence in ABCA4-Related Retinopathy
por: Müller, Philipp L., et al.
Publicado: (2018)

Progression of Age-Related Macular Degeneration Among Individuals Homozygous for Risk Alleles on Chromosome 1 (CFH-CFHR5) or Chromosome 10 (ARMS2/HTRA1) or Both
por: Schmitz-Valckenberg, Steffen, et al.
Publicado: (2022)

Non-Neovascular Pachychoroid Disease Mimicking Exudative Age-Related Macular Degeneration
por: Kaseewat, Thachpacha, et al.
Publicado: (2021)

A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration—the FALCON study
por: Holz, F. G., et al.
Publicado: (2022)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

The Diagnostic Capability of Swept Source OCT Angiography in Treatment-Naive Exudative Neovascular Age-Related Macular Degeneration
por: Ahmed, Daniel, et al.
Publicado: (2021)

Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
por: Wachtlin, Joachim, et al.
Publicado: (2020)

Validation of an Automated Quantification of Relative Ellipsoid Zone Reflectivity on Spectral Domain-Optical Coherence Tomography Images
por: Thiele, Sarah, et al.
Publicado: (2020)

Effect of topical isopropyl unoprostone on macular atrophy progression in eyes with exudative age-related macular degeneration
por: Shiragami, Chieko, et al.
Publicado: (2017)

Algorithms for the Automated Analysis of Age-Related Macular Degeneration Biomarkers on Optical Coherence Tomography: A Systematic Review
por: Wintergerst, Maximilian W.M., et al.
Publicado: (2017)

The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration
por: Inan, Sibel, et al.
Publicado: (2019)

Unilateral macular exudation
por: Khanum, Aayesha, et al.
Publicado: (2021)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
por: Griffin, David R., et al.
Publicado: (2014)

Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept
por: Sato, Tomohito, et al.
Publicado: (2021)

Swept-Source OCT Angiographic Characteristics of Treatment-Naïve Nonexudative Macular Neovascularization in AMD Prior to Exudation
por: Shen, Mengxi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t21bj67ram5oaj67arerb3b3bn